Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination

Ann Hematol. 2022 Apr;101(4):927-928. doi: 10.1007/s00277-021-04611-y. Epub 2021 Aug 10.

Authors

Marcel Kemper¹, Christoph Berssenbrügge², Georg Lenz³, Rolf Michael Mesters³

Affiliations

¹ Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany. Marcel.Kemper@ukmuenster.de.
² General Practitioner, Bittgang 28, 49393, Lohne, Germany.
³ Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

No abstract available

Publication types

Letter

MeSH terms

Ad26COVS1
COVID-19* / prevention & control
Humans
Thrombocytopenia* / chemically induced
Vaccination / adverse effects
Vaccines*

Substances

Ad26COVS1
Vaccines